In adults with HIV and low-to-moderate CV risk, pitavastatin reduced MACE over a median 5.1 y
- PMID: 37931263
- DOI: 10.7326/J23-0083
In adults with HIV and low-to-moderate CV risk, pitavastatin reduced MACE over a median 5.1 y
Abstract
Grinspoon SK, Fitch KV, Zanni MV, et al; REPRIEVE Investigators. Pitavastatin to prevent cardiovascular disease in HIV infection. N Engl J Med. 2023;389:687-699. 37486775.
Conflict of interest statement
Comment on
-
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. Update in: N Engl J Med. 2024 May 2;390(17):1626-1628. doi: 10.1056/NEJMc2400870. PMID: 37486775 Free PMC article. Updated. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical